Literature DB >> 7288596

Simultaneous pharmacokinetic and pharmacodynamic modeling.

W A Colburn.   

Abstract

The compartmental model approach previously proposed by Sheiner et al. for the simultaneous characterization of the pharmacokinetics and pharmacodynamics of a drug substance has been rigorously tested and extended in the present report. Pharmacokinetic and pharmacodynamic equations were derived for several commonly used models, as well as alternate models that relate effect to drug concentrations in a peripheral compartment. The versatility and flexibility of these models were tested using simulation and curve-fitting procedures. The utility as well as the limitations of this modeling procedure are discussed.

Mesh:

Substances:

Year:  1981        PMID: 7288596     DOI: 10.1007/BF01059272

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  4 in total

1.  Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man.

Authors:  J G Wagner
Journal:  J Theor Biol       Date:  1968-08       Impact factor: 2.691

2.  Relationship between blood levels and analgesic effects of acetaminophen in mice.

Authors:  J Shibasaki; R Konishi; T Kitasaki; T Koizumi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1979-01       Impact factor: 1.645

3.  Pharmacokinetic and pharmacodynamic tolerance of a new anticonvulsant agent (3-sulfamoylmethyl-1,2-benzisoxazole) compared to phenobarbital, diphenylhydantoin and carbamazepine in rats.

Authors:  Y Masuda; Y Utsui; Y Shiraishi; T Karasawa; K Yoshida; M Shimizu
Journal:  Arch Int Pharmacodyn Ther       Date:  1979-07

4.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

  4 in total
  32 in total

1.  Peripheral link model as an alternative for pharmacokinetic-pharmacodynamic modeling of drugs having a very short elimination half-life.

Authors:  J Laurin; F Donati; F Nekka; F Varin
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

2.  Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives.

Authors:  H Derendorf; B Meibohm
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

Review 3.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

4.  A clinical pharmacological assessment of doxazosin and enalapril in combination.

Authors:  A D Bainbridge; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

5.  Hearing impairment related to plasma quinine concentration in healthy volunteers.

Authors:  G Alván; K K Karlsson; U Hellgren; T Villén
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

Review 6.  Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors:  W A Colburn; M L Jack
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

7.  Pharmacokinetic and pharmacodynamic of irbesartan in renal hypertensive dogs under non-steady-state and steady-state conditions.

Authors:  Xiao-Hui Huang; Fu-Rong Qiu; Hai-Tang Xie; Jun Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

8.  Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experiments.

Authors:  Andrew Hooker; Paolo Vicini
Journal:  AAPS J       Date:  2005-11-01       Impact factor: 4.009

9.  PK-PD modeling of irbesartan in healthy Chinese adult volunteers under non-steady-state conditions.

Authors:  Xiao-Hui Huang; Jun Li; Fu-Rong Qiu; Hai-Tang Xie; Ji-Han Huang; Jian-Chun Li; Qing-Shan Zheng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Oct-Dec       Impact factor: 2.441

10.  A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs.

Authors:  F Donati; C Meistelman
Journal:  J Pharmacokinet Biopharm       Date:  1991-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.